A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma

Clinical trial NCT04653038 · TERMINATED

Trial details

NCT number: NCT04653038
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Unresectable, Recurrent or Metastatic Melanoma Untreated Mucosal or Acral Lentiginous Melanoma

Start date: 2020-10-29
Primary completion: 2022-03-02
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.